194 related articles for article (PubMed ID: 16550200)
1. Cross-priming.
Bevan MJ
Nat Immunol; 2006 Apr; 7(4):363-5. PubMed ID: 16550200
[No Abstract] [Full Text] [Related]
2. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
3. The cross-priming pathway: a portrait of an intricate immune system.
Basta S; Alatery A
Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
[TBL] [Abstract][Full Text] [Related]
4. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions.
Stelekati E; Bahri R; D'Orlando O; Orinska Z; Mittrücker HW; Langenhaun R; Glatzel M; Bollinger A; Paus R; Bulfone-Paus S
Immunity; 2009 Oct; 31(4):665-76. PubMed ID: 19818652
[TBL] [Abstract][Full Text] [Related]
5. Immunology. Nothing 'gainst time's scythe can make defense..
Ploegh HL
Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
[No Abstract] [Full Text] [Related]
6. Cross-priming: its beginnings.
Carbone FR; Heath WR
J Immunol; 2010 Aug; 185(3):1353-4. PubMed ID: 20660358
[No Abstract] [Full Text] [Related]
7. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
[TBL] [Abstract][Full Text] [Related]
8. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
[TBL] [Abstract][Full Text] [Related]
9. The good fat: a link between lipid bodies and antigen cross-presentation.
Desjardins M
Immunity; 2009 Aug; 31(2):176-8. PubMed ID: 19699167
[TBL] [Abstract][Full Text] [Related]
10. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
Kim S; Shen T; Min B
J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
[TBL] [Abstract][Full Text] [Related]
11. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses.
Bedoui S; Prato S; Mintern J; Gebhardt T; Zhan Y; Lew AM; Heath WR; Villadangos JA; Segura E
J Immunol; 2009 Apr; 182(7):4200-7. PubMed ID: 19299718
[TBL] [Abstract][Full Text] [Related]
14. Y in X priming.
Amigorena S
Nat Immunol; 2003 Nov; 4(11):1047-8. PubMed ID: 14586419
[No Abstract] [Full Text] [Related]
15. Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.
Chen W; Masterman KA; Basta S; Haeryfar SM; Dimopoulos N; Knowles B; Bennink JR; Yewdell JW
Eur J Immunol; 2004 Jan; 34(1):194-9. PubMed ID: 14971045
[TBL] [Abstract][Full Text] [Related]
16. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
17. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
[TBL] [Abstract][Full Text] [Related]
18. Bioorthogonal deprotection on the dendritic cell surface for chemical control of antigen cross-presentation.
Pawlak JB; Gential GP; Ruckwardt TJ; Bremmers JS; Meeuwenoord NJ; Ossendorp FA; Overkleeft HS; Filippov DV; van Kasteren SI
Angew Chem Int Ed Engl; 2015 May; 54(19):5628-31. PubMed ID: 25784151
[TBL] [Abstract][Full Text] [Related]
19. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. 1976.
Bevan MJ
J Immunol; 2010 Aug; 185(3):1355-60. PubMed ID: 20660359
[No Abstract] [Full Text] [Related]
20. Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.
Schildknecht A; Probst HC; McCoy KD; Miescher I; Brenner C; Leone DP; Suter U; Ohashi PS; van den Broek M
Eur J Immunol; 2009 Jun; 39(6):1505-15. PubMed ID: 19462379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
